Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Plos One|April 16, 2011
Solid-phase microextraction and the human fecal VOC metabolomeEmma Dixon, Cynthia Clubb, Sara Pittman, et al.
Molecules (Basel, Switzerland)|February 26, 2014
Synthetic Fosmidomycin analogues with altered chelating moieties do not inhibit 1-deoxy-d-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum growth in vitroRené Chofor, Martijn D P Risseeuw, Jenny Pouyez, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|April 9, 2022
Penetrating colon trauma - outcomes related to single versus multiple colonic injuriesG V Oosthuizen, J Klopper, J Buitendag, et al.
Molecular Pharmacology|January 13, 2006
2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosisRobin D Couch, Neil J Ganem, Ming Zhou, et al.
ACS Omega|November 1, 2021
Mechanism of Action of N-Acyl and N-Alkoxy Fosmidomycin Analogs: Mono- and Bisubstrate Inhibition of IspC from Plasmodium falciparum, a Causative Agent of MalariaMisgina B Girma, Haley S Ball, Xu Wang, et al.
Plos One|October 19, 2012
Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacyElizabeth S McKenney, Michelle Sargent, Hameed Khan, et al.
Journal of Medicinal Chemistry|September 17, 2004
Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targetsTadashi Honda, Tomasz Janosik, Yukiko Honda, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2013
The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogsEmily R Jackson, Géraldine San Jose, Robert C Brothers, et al.
Medchemcomm|August 6, 2013
Design of Potential Bisubstrate Inhibitors against Mycobacterium tuberculosis (Mtb) 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (Dxr)-Evidence of a Novel Binding ModeGéraldine San Jose, Emily R Jackson, Eugene Uh, et al.
ESMO Open|April 10, 2025
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine)D Malka, I Borbath, A Lopes, et al.
Pageof 6